[1] Liu P, Xie SH, Hu S, et al. Age-specific sex difference in the incidence of hepatocellular carcinoma in the United States. Oncotarget, 2017, 8:68131-68137.
[2] 王丽, 陈竹. 肝细胞癌的影像学诊断进展. 肝脏, 2017, 22:265-267.
[3] 北方肝癌治疗专家委员会. 北方肝癌治疗专家委员会肝细胞癌诊疗共识(草案). 肝癌电子杂志, 2014, 1:1-13.
[4] 陈敏华, 严昆, 戴莹,等. 肝超声造影应用指南(2012年修改版). 中华超声影像学杂志, 2013, 22:696-722.
[5] Tokumitsu Y, Sakamoto K, Tokuhisa Y, et al. A new prognostic model for hepatocellular carcinoma recurrence after curative hepatectomy. Oncol Lett, 2018, 15:4411-4422.
[6] Zou H, Zhu CZ, Wang C, et al. Recurrence of barcelona clinic liver cancer stage a hepatocellular carcinoma after hepatectomy. Am J Med Sci, 2017, 354:262-267.
[7] 李惠, 王绮, 袁建军,等. 小肝细胞性肝癌迟发性复发病灶超声造影特征观察. 中华超声影像学杂志, 2016, 25:776-779.
[8] Maruyama H, Sekimoto T, Yokosuka O. Role of contrast-enhanced ultrasonography with sonazoid for hepatocellular carcinoma: evidence from a 10-year experience. J Gastroenterol, 2016, 51:421-433. |
